Related Experiment Video

Updated: Aug 4, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

HCV confirmatory testing of blood donors

E A Follett, B C Dow, F McOmish

    Lancet (London, England)
    |October 19, 1991
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
    11:28

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

    Published on: March 13, 2015

    Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
    11:59

    Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

    Published on: September 6, 2017

    Related Experiment Videos

    Last Updated: Aug 4, 2026

    High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
    09:00

    High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

    Published on: October 31, 2012

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
    11:28

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

    Published on: March 13, 2015

    Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
    11:59

    Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

    Published on: September 6, 2017

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

    Articles linked to this work by shared authors, journal, and citation graph.

    Human immunodeficiency virus 1 subtypes detected in Scottish blood donors.

    Vox sanguinis·2009

    Benefits of a blood donation archive repository: international survey of donor repository procedures and Scottish experiences.

    Transfusion·2007

    Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.

    Vox sanguinis·2006

    Comparison of prevalence rates of microbiological markers between bone/tissue donations and new blood donors in Scotland.

    Vox sanguinis·2006

    Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.

    Vox sanguinis·2005

    Hepatitis B virus genotypes and precore mutations in Scottish blood donors.

    Vox sanguinis·2005

    Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.

    Lancet (London, England)·2026

    Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care.

    Lancet (London, England)·2026

    Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study.

    Lancet (London, England)·2026

    Adverse pregnancy outcomes and long-term cardiovascular disease risk.

    Lancet (London, England)·2026

    Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.

    Lancet (London, England)·2026

    Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial.

    Lancet (London, England)·2026

    Successful treatment of refractory hemophagocytic lymphohistiocytosis complicating Epstein-Barr virus-positive classic Hodgkin lymphoma with rituximab.

    Journal of clinical and experimental hematopathology : JCEH·2026

    [Complement-coagulation crosstalk in immunothrombosis].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Hematological diseases caused by excessive complement activation].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Utility of global coagulation assays for hemostasis management in hyperclearance-type autoimmune acquired coagulation factor V deficiency].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    Association of Pretreatment Hepatic Function Markers with Clazosentan-Associated Fluid Retention in Patients with Subarachnoid Hemorrhage.

    Biological & pharmaceutical bulletin·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us